Company / Goodwill
Avalo Therapeutics, Inc. Goodwill History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$10.5M
FY2025
5-year range
$10.5M / $14.4M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$11M in FY2025 with a 5-year CAGR of -6.1%.
Remained stable around $11M over the past 2 years.
Goodwill over time
Growth rates
- 3-Year CAGR
- -10.0%
- 5-Year CAGR
- -6.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -6.1%, indicating a declining trend.
- In FY2025, goodwill increased 0.0% year-over-year.
- Peak goodwill was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.5M | +0.0% |
| FY2024 | $10.5M | +0.0% |
| FY2023 | $10.5M | -27.1% |
| FY2022 | $14.4M | +0.0% |
| FY2021 | $14.4M | +0.0% |
| FY2020 | $14.4M | -0.0% |
| FY2019 | $14.4M | +0.0% |
| FY2018 | $14.4M | +17.2% |
| FY2017 | $12.3M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026